Generation Bio (GBIO) Stock Statistics & Valuation Metrics

Generation Bio has a market cap or net worth of $27.15M. The enterprise value is -$34.58M.

Generation Bio has 6,735,544 shares outstanding. The number of shares has decreased by -2.65% in one year.

Generation Bio’s return on equity (ROE) is -1.53 and return on invested capital (ROIC) is -64.10%.

The current PE Ratio of Generation Bio is ―. Generation Bio’s PEG ratio is ―.

In the last 12 months, Generation Bio had revenue of 19.89M and earned -131.67M in profits. Earnings per share was -19.76.

In the last 12 months, operating cash flow was -80.52M and capital expenditures -1.17M, giving a free cash flow of -81.69M billion.

Generation Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Generation Bio upcoming earnings date is Nov 5, 2025, Before Open (Confirmed).

Generation Bio as a current ratio of 5.50, with Debt / Equity ratio of 157.71%

In the past 12 months, Generation Bio has paid 0.00 in taxes.

Generation Bio EV to EBITDA ratio is -1.18, with an EV/FCF ratio of -0.97.

Generation Bio has $141.36M in cash and marketable securities with $85.32M in debt, giving a net cash position of -$56.04M billion.

Gross margin is 96.40%, with operating margin of -715.82%, and net profit margin of -661.91%.

The average price target for Generation Bio is $10.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy